+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Autoinjectors - Global Strategic Business Report - Product Thumbnail Image

Autoinjectors - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
From
B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Refractory Multiple Myeloma - Pipeline Insight, 2024 - Product Thumbnail Image

Refractory Multiple Myeloma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
From
From
Pediatric Neuroblastoma Treatment Global Market Report 2024 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Biosimilars Market Report and Forecast 2023-2031 - Product Thumbnail Image

Biosimilars Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
Lupus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Lupus Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 182 Pages
  • Global
From
Immuno-Oncology - Global Strategic Business Report - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report

  • Report
  • November 2024
  • 224 Pages
  • Global
From
Loading Indicator